Concepedia

Publication | Closed Access

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

966

Citations

32

References

1999

Year

TLDR

Three human subjects who mistakenly self‑administered MPTP developed severe, L‑dopa‑responsive parkinsonism, and although the mechanism remains unclear, these cases suggest a time‑limited insult can trigger a self‑perpetuating neurodegenerative process with broad implications. This study presents the first detailed neuropathological examination of MPTP‑induced parkinsonism in humans. Post‑mortem analysis revealed 3–16 year survival, moderate‑to‑severe loss of pigmented substantia nigra neurons, absence of Lewy bodies, gliosis with microglial clustering, extraneuronal melanin, and evidence of ongoing neurodegeneration, indicating that a brief insult can initiate a self‑sustaining degenerative cascade.

Abstract

This report provides the first detailed neuropathological study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in humans. All 3 subjects self-administered the drug under the impression it was "synthetic heroin" and subsequently developed severe and unremitting parkinsonism, which was L-dopa responsive, at least in the earlier stages of illness. Survival times ranged from 3 to 16 years. Neuropathological examination revealed moderate to severe depletion of pigmented nerve cells in the substantia nigra in each case. Lewy bodies were not present. In Patients 1 and 2, there was gliosis and clustering of microglia around nerve cells. Patient 3 had a similar picture and also showed large amounts of extraneuronal melanin. These findings are indicative of active, ongoing nerve cell loss, suggesting that a time-limited insult to the nigrostriatal system can set in motion a self-perpetuating process of neurodegeneration. Although the mechanism by which this occurs is far from clear, the precedent set by the cases could have broad implications for human neurodegenerative disease.

References

YearCitations

Page 1